Previous Close | 68.10 |
Open | 68.10 |
Bid | 68.30 x 1500 |
Ask | 68.30 x 8800 |
Day's Range | 68.10 - 68.50 |
52 Week Range | 14.52 - 69.75 |
Volume | |
Avg. Volume | 250,261 |
Market Cap | 2.574B |
Beta (5Y Monthly) | 0.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.